(Q42658845)

English

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

scientific article published on September 2010

Statements

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study (English)
Hans Jürgen Stellbrink
Marie-Aude Khuong-Josses

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit